Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10118963 Antigen binding proteins that bind PD-L1

Patent 10118963 was granted and assigned to Sorrento Therapeutics on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Sorrento Therapeutics
Sorrento Therapeutics
Date Filed
January 27, 2017
Date of Patent
November 6, 2018
Patent Applicant
Sorrento Therapeutics
Sorrento Therapeutics
Patent Application Number
15418514
Patent Citations Received
‌
US Patent 11919952 Antigen binding proteins that bind PD-L1
0
‌
US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies
‌
US Patent 11773175 Antibodies, uses and methods
‌
US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods
‌
US Patent 11878058 Antigen binding proteins that bind PD-L1
0
‌
US Patent 10604576 Antibodies and immunocytokines
‌
US Patent 10919964 Antigen binding proteins that bind PD-L1
‌
US Patent 11027012 Antigen binding proteins that bind PD-L1
0
Patent Inventor Names
Heyue Zhou
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10118963
Patent Primary Examiner
‌
Jessica H Roark

Find more entities like US Patent 10118963 Antigen binding proteins that bind PD-L1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.